Successful treatment of trichothiodystrophy with dupilumab

Clin Exp Dermatol. 2021 Oct;46(7):1381-1383. doi: 10.1111/ced.14642. Epub 2021 May 6.

Authors

R Gruber¹, A Zschocke², H Zellner³, M Schmuth¹

Affiliations

¹ Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.
² Department of Pediatrics, Pediatrics III, Medical University of Innsbruck, Innsbruck, Austria.
³ Department of Pediatrics, Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Abstract

Click here for the corresponding questions to this CME article.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Child
Humans
Injections, Subcutaneous
Interleukin-4 Receptor alpha Subunit / antagonists & inhibitors*
Male
Receptors, Interleukin-13 / antagonists & inhibitors
Trichothiodystrophy Syndromes / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Interleukin-4 Receptor alpha Subunit
Receptors, Interleukin-13
dupilumab